Takeda Pharmaceutical Financials
| TAK Stock | USD 14.36 0.28 1.99% |
Takeda |
Takeda Pharmaceutical Stock Summary
Takeda Pharmaceutical competes with Viatris, Elanco Animal, Zoetis, Emergent Biosolutions, and Prestige Brand. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 47347 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US8740602052 |
| CUSIP | 874060205 874060106 |
| Location | Japan |
| Business Address | 1-1, Nihonbashi-Honcho 2-chome, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.takeda.com |
| Phone | 81 3 3278 2111 |
| Currency | USD - US Dollar |
Takeda Pharmaceutical Key Financial Ratios
| Return On Equity | 0.0294 | ||||
| Return On Asset | 0.0251 | ||||
| Target Price | 16.31 | ||||
| Beta | 0.46 | ||||
| Last Dividend Paid | 192.0 |
Takeda Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Takeda Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Takeda Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Takeda Pharmaceutical competition to find correlations between indicators driving Takeda Pharmaceutical's intrinsic value. More Info.Takeda Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Takeda Pharmaceutical Co is roughly 1.17 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Takeda Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Takeda Pharmaceutical Systematic Risk
Takeda Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Takeda Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Takeda Pharmaceutical correlated with the market. If Beta is less than 0 Takeda Pharmaceutical generally moves in the opposite direction as compared to the market. If Takeda Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Takeda Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Takeda Pharmaceutical is generally in the same direction as the market. If Beta > 1 Takeda Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Takeda Pharmaceutical February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Takeda Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Takeda Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Takeda Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Takeda Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.24 | |||
| Information Ratio | 0.0715 | |||
| Maximum Drawdown | 5.19 | |||
| Value At Risk | (2.04) | |||
| Potential Upside | 2.71 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.